• HER2/neu (ERBB2), IHC, Semi-Quantitative, Other Tissue
  • Amyloid Protein Identification
  • Pneumocystis jirovecii Antigen, DFA
  • Phenosense HIV Drug Resistance Replication Capacity
  • Beta-2 Microglobulin, Serum
  • Lactate Dehydrogenase (LDH) Isoenzymes
  • Treponema pallidum Antibody, FTA-ABS, IgG, CSF
  • Porphyrins, Quantitative, 24 Hour, Urine
  • Brucella Antibody, IgG and IgM
  • Wet Mount from Vaginal Fluid (Vaginal Swab)
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /c-KIT Mutation Analysis, Tissue
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

c-KIT Mutation Analysis, Tissue
Medical Test

Methodology
Access to c-KIT Mutation Analysis, Tissue is restricted.
Loading...